Merck (MRCG.DE), a German pharmaceutical company, said on Monday that Helene von Roeder would replace Marcus Kuhnert as CFO and a member of the Executive Board.
The business said the adjustments will take effect on July 1.
This month, German real estate firm Vonovia (VNAn.DE) stated that von Roeder would be voluntarily stepping down from the company’s management board from July 1.

